Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Receptor Protein-Tyrosine Kinases × Clear all

NCT00677326 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms